Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>AOTI Inc 32.50p £39.35m (AOTI.L) The medical technology Company focused on delivering outcomes-based care at home updates on trading for the FY December 2025.</li>
<li>Revenue is expected to increase 14% to $66.5m which is inline as is EBITDA at c. $5.9m.</li>
<li>Net debt increased to c.$6.5m with funding in place to support its ongoing working capital needs. </li>
</ul>


AOTI Inc 32.50p £39.35m (AOTI.L) The medical technology Company focused on delivering outcomes-based care at home updates on trading for the FY December 2025.
Revenue is expected to increase 14% to $66.5m which is inline as is EBITDA at c. $5.9m.
Net debt increased to c.$6.5m with funding in place to support its ongoing working capital needs. 


Victoria PLC - Hybridan Small Cap Feast: 23 February 2026